Bevacizumab in advanced cancer, too much or too little?

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 19; no. 10; pp. 1817 - 1818
Main Authors Jirillo, A., Vascon, F., Giacobbo, M.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2008
Oxford University Press
Oxford Publishing Limited (England)
Subjects
Angiogenesis Inhibitors - economics
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal - economics
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Drug Costs
Humans
Neoplasms - drug therapy
Neoplasms - economics
Online AccessGet full text

Cover

More Information
Bibliography:istex:513CAF37FFBDF3FB7BAF5481A3C5A1FA8C5F34A9
ark:/67375/HXZ-GW90V4FV-0
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdn564